000 00985 a2200265 4500
005 20250513175241.0
264 0 _c19990513
008 199905s 0 0 eng d
022 _a0049-3848
024 7 _a10.1016/s0049-3848(98)00206-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWade, W E
245 0 0 _aCost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients.
_h[electronic resource]
260 _bThrombosis research
_cApr 1999
300 _a65-8 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article; Review
650 0 4 _aCost-Benefit Analysis
650 0 4 _aHeparin
_xtherapeutic use
650 0 4 _aHeparin, Low-Molecular-Weight
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aVenous Thrombosis
_xeconomics
700 1 _aChisholm, M A
773 0 _tThrombosis research
_gvol. 94
_gno. 1
_gp. 65-8
856 4 0 _uhttps://doi.org/10.1016/s0049-3848(98)00206-0
_zAvailable from publisher's website
999 _c10172418
_d10172418